Quest Diagnostics (DGX) Operating Leases (2019 - 2026)

Quest Diagnostics (DGX) has 8 years of Operating Leases data on file, last reported at $574.0 million in Q1 2026.

• Quarterly Operating Leases rose 6.69% year-over-year to $574.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $574.0 million (up 6.69% YoY) and the FY2025 annual result came in at $537.0 million, down 25.93% from the prior year.
• Operating Leases climbed to $574.0 million in Q1 2026 per DGX's latest filing, from $537.0 million in the prior quarter.
• The five-year high for Operating Leases was $725.0 million in Q4 2024, with the low at $489.0 million in Q4 2022.
• Average Operating Leases over 5 years is $529.8 million, with a median of $508.0 million recorded in 2023.
• Year-over-year, Operating Leases dropped 27.98% in 2022 and soared 44.14% in 2024.
• Quest Diagnostics' Operating Leases stood at $489.0 million in 2022, then climbed by 2.86% to $503.0 million in 2023, then jumped by 44.14% to $725.0 million in 2024, then retreated by 25.93% to $537.0 million in 2025, then gained by 6.89% to $574.0 million in 2026.
• Business Quant data shows DGX's Operating Leases at $574.0 million in Q1 2026, $537.0 million in Q4 2025, and $534.0 million in Q3 2025.